The company has developed a platform that utilizes their proprietary single-molecule detection technology to offer full spatial context at subcellular resolution while preserving the sample tissue. This technology enables scientists to detect individual transcripts and rare signals, leading to new insights and advancements in fields such as oncology, neuroscience, and infectious disease. Resolve Biosciences' platform is currently available through an oversubscribed early access program and aims to lead the next generation of single-cell analysis in the biotechnology field.